Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China · Delayed Price · Currency is CNY 24.34
-0.47 (-1.89%)
Oct 14, 2026, 11:29 AM CST
SHA:605177 Market Cap
SHA:605177 has a market cap or net worth of 2.74 billion as of October 13, 2026. It is the 16,326th most valuable company in the world and the 4,488th biggest in China. Its market cap has increased by 28.17% in one year.
Market Cap
2.74B
Enterprise Value
3.26B
Revenue
990.47M
Global Rank
Country Rank
#4,488 China
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2020, SHA:605177's market cap has decreased from 5.09B to 2.74B, a decrease of -46.21%. That is a compound annual growth rate of -10.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 2.74B | 36.73% |
| Dec 31, 2025 | 2.00B | -9.67% |
| Dec 31, 2024 | 2.22B | -26.27% |
| Dec 29, 2023 | 3.01B | 32.27% |
| Dec 30, 2022 | 2.27B | -27.57% |
| Dec 31, 2021 | 3.14B | -22.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 3.52B |
| Qingdao Vland Biotech INC. | 3.50B |
| Lifecome Biochemistry | 3.43B |
| Shanghai Shen Lian Biomedical | 3.42B |
| Guanhao Biotech | 3.25B |
| Baolingbao Biology | 3.22B |
| Hinova Pharmaceuticals | 3.18B |
| Shanghai Universal Biotech | 3.10B |